CGB3
Basic information
Region (hg38): 19:49022869-49024333
Previous symbols: [ "CGB" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (3 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CGB3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000737.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 3 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 2 | 3 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CGB3 | protein_coding | protein_coding | ENST00000357383 | 3 | 1465 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0983 | 0.596 | 125487 | 0 | 18 | 125505 | 0.0000717 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.942 | 61 | 43.5 | 1.40 | 0.00000296 | 1014 |
Missense in Polyphen | 20 | 17.202 | 1.1627 | 482 | ||
Synonymous | -1.85 | 27 | 17.2 | 1.57 | 0.00000107 | 356 |
Loss of Function | 0.123 | 1 | 1.14 | 0.876 | 4.90e-8 | 35 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Beta subunit of the human chorionic gonadotropin (hCG). hCG is a complex glycoprotein composed of two glycosylated subunits alpha and beta which are non-covalently associated. The alpha subunit is identical to those in the pituitary gonadotropin hormones (LH, FSH and TSH). The beta subunits are distinct in each of the hormones and confer receptor and biological specificity. Has an essential role in pregnancy and maternal adaptation. Stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy. {ECO:0000305}.;
- Pathway
- Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Gene expression (Transcription);Peptide hormone metabolism;Generic Transcription Pathway;Metabolism of proteins;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;RNA Polymerase II Transcription;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;GPCR signaling-G alpha i;Glycoprotein hormones;Peptide hormone biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.0967
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.187
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;apoptotic process;signal transduction;G protein-coupled receptor signaling pathway;cell-cell signaling;female gamete generation;hormone-mediated signaling pathway;regulation of signaling receptor activity;peptide hormone processing
- Cellular component
- extracellular region;extracellular space;cytoplasm
- Molecular function
- hormone activity